In this video, Professor John Hardy reviews key discoveries in the genetics of neurodegenerative disease. These range from early-onset Alzheimer’s mutations in APP and the presenilins, and tau mutations in frontotemporal dementia, to late-onset risk genes such as TREM2 that point to a central role for microglia in clearing pathology.
In Parkinson’s disease, research has moved from the first finding of α-synuclein to 40–50 genes, many involved in lysosomal and mitochondrial clearance pathways.
Last reviewed on 16-09-2026.